What is the presentation of multiple myeloma?
One of the first things that doctors try to do when the patient is diagnosed with multiple myeloma is to determine the condition. The so -called multiple staging myeloma involves examining the disease indicators to see how far the condition has advanced and how much it has already affected the patient's marrow and bone. Based on this information, the doctor may map the course of treatment and have a better sense of prognosis of the patient. They are bone lesions or pain, reduced kidney function, increased calcium levels in the blood and anemia. Patients without apparent symptoms have an inactive multiple myeloma, also called smoldering multiple myeloma. If the doctor determines this during the performance of multiple myeloma, he will still carefully monitor the patient in the future. The physician may also propose some Medications to protect the patient from potential side effects, such as drugs to strengthen bones or vaccination against certain types of infections.
If the patient corresponds to the symptoms of multiple myeloma, then it is considered to be an active case. A patient who shows higher protein levels in their urine or blood or shows in particular organ damage could then require immediate treatment. Other symptoms that doctors can observe during staging multiple myeloma include repeated infections and amyloidosis, unusual accumulation of proteins in certain organs.
The name of the traditional system of the introduction of more myeloma is called the Durie-Salmon system. It allows doctors to know which of the three phases have achieved an active case of multiple myeloma. Each of the three phases in this system is also divided into two subcategories, based on Whetjei disease affected the patient's kidneys.
6 Based on the levels of certain proteins in the blood, this system also divides cases into three phases. The stage and myeloma are diagnosed when the patient has, among other things, symptoms of almost normal red blood cells, normal calcium levels, very low blood levelsH proteins and no bone damage. In myeloma II II contains the body of the patient more cancer cells. Patients with myeloma in phase III show bone damage, anemia, many cancer cells in the body and higher blood protein levels, including symptoms.